FGF18 inhibits MC3T3‑E1 cell osteogenic differentiation via the ERK signaling pathway

  • Authors:
    • Feng Zhai
    • Na Song
    • Jisheng Ma
    • Weiyue Gong
    • Haishan Tian
    • Xiaokun Li
    • Chao Jiang
    • Haijun Wang
  • View Affiliations

  • Published online on: July 26, 2017     https://doi.org/10.3892/mmr.2017.7088
  • Pages: 4127-4132
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Fibroblast growth factor (FGF) 18 is a member of the FGF family and serves a key role in skeletal growth and development. The present study investigated the effect of FGF18 on pre‑osteoblast MC3T3-E1 cells and the signaling pathways involved by performing an alkaline phosphatase (ALP) assay and reverse transcription‑quantitative polymerase chain reaction. MC3T3‑E1 cells incubated in a culture medium supplemented with FGF18 exhibited increased viability when compared with the untreated control cells. In addition, ALP activity was decreased in MC3T3‑E1 cells treated with FGF18 plus an osteogenic medium (OM) for 7 and 14 days when compared with untreated and OM‑treated controls. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) results demonstrated that the expression of osteoblastic‑associated genes was significantly repressed in FGF18 plus OM‑treated MC3T3‑E1 cells, including ALP, collagen type I, osteocalcin, bone sialo protein and osterix. These results suggested that the expression levels of genes associated with osteogenesis were mainly repressed. In addition, combined treatment of MC3T3‑E1 cells with OM and FGF18 led to a significant reduction in mineral deposition when compared with the OM‑only treated group. Furthermore, FGF18 activated the extracellular signal‑regulated kinase pathway in MC3T3‑E1 cells, which may have been responsible for the observed decrease in the expression of osteoblastic‑associated genes. In conclusion, the results suggest that FGF18 may be involved in MC3T3‑E1 cell proliferation and osteoblastic differentiation.

Related Articles

Journal Cover

October-2017
Volume 16 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhai F, Song N, Ma J, Gong W, Tian H, Li X, Jiang C and Wang H: FGF18 inhibits MC3T3‑E1 cell osteogenic differentiation via the ERK signaling pathway. Mol Med Rep 16: 4127-4132, 2017
APA
Zhai, F., Song, N., Ma, J., Gong, W., Tian, H., Li, X. ... Wang, H. (2017). FGF18 inhibits MC3T3‑E1 cell osteogenic differentiation via the ERK signaling pathway. Molecular Medicine Reports, 16, 4127-4132. https://doi.org/10.3892/mmr.2017.7088
MLA
Zhai, F., Song, N., Ma, J., Gong, W., Tian, H., Li, X., Jiang, C., Wang, H."FGF18 inhibits MC3T3‑E1 cell osteogenic differentiation via the ERK signaling pathway". Molecular Medicine Reports 16.4 (2017): 4127-4132.
Chicago
Zhai, F., Song, N., Ma, J., Gong, W., Tian, H., Li, X., Jiang, C., Wang, H."FGF18 inhibits MC3T3‑E1 cell osteogenic differentiation via the ERK signaling pathway". Molecular Medicine Reports 16, no. 4 (2017): 4127-4132. https://doi.org/10.3892/mmr.2017.7088